Related Experiment Video

Updated: Jun 7, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

Developing evidence-based Korean medicine clinical practice guidelines for pediatric anorexia

Juhui Han1, Sun Haeng Lee1, Miran Bang2

  • 1Department of Korean Pediatrics, College of Korean Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea.

BMC Complementary Medicine and Therapies
|June 5, 2026
PubMed

Insights

Korean medicine offers effective treatments for pediatric anorexia, improving growth and development. These evidence-based guidelines provide standardized care, enhancing clinical practice and future research for children

Area of Science:

  • Pediatric Gastroenterology
  • Integrative Medicine
  • Evidence-Based Practice

Background:

  • Pediatric anorexia impacts children's physical growth, nutrition, and psychosocial development.
  • Standardized Korean medicine treatment guidelines for pediatric anorexia are lacking.
  • This study addresses the need for evidence-based Korean Medicine Clinical Practice Guidelines (KM-CPGs).

Purpose of the Study:

  • To develop standardized, evidence-based Korean Medicine Clinical Practice Guidelines (KM-CPGs) for pediatric anorexia.
  • To support clinical decision-making in pediatric anorexia management.
  • To ensure safe and effective Korean medicine care for children.

Main Methods:

  • Developed KM-CPGs using systematic reviews, meta-analyses, and expert consensus (Delphi method).
  • Employed the Grading of Recommendation Assessment, Development, and Evaluation (GRADE) approach for evidence and recommendations.
  • Focused on Korean medicine interventions including herbal medicine, acupuncture, Chuna manual therapy, and acupoint herbal patching.

Main Results:

  • Generated 15 key recommendations for Korean medicine interventions in pediatric anorexia.
  • Korean medicine treatments, as monotherapies or adjuncts, showed meaningful improvements in anorexia-related outcomes.
  • Interventions demonstrated a low risk of adverse events, despite moderate to low evidence levels.

Conclusions:

  • The developed KM-CPGs offer standardized, evidence-based guidance for Korean medicine treatments in pediatric anorexia.
  • These guidelines can form the basis for improved clinical care and future research.
  • Standardized guidelines are crucial for advancing the integration of Korean medicine in pediatric care.
Abstract

Keywords:
AcupunctureChuna manual therapyClinical practice guidelineEvidence-based medicineHerbal medicineKorean medicinePediatric anorexia

Related Concept Videos

Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...